Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers. The ...

Humacyte's stock struggles despite FDA approval for Symvess, with financial concerns and slow adoption impacting future ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Researchers at Saratov State University and their colleagues have developed an innovative approach to improving the ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

Planned single, pivotal Phase 2/3 clinical trial, if positive, acceptable for Biological License Application (BLA) submission for Alzheimer’s ...

Researchers provide a conceptual overview of liver vasomics, including the classification of vascular phenotypes in the liver ...

A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...

Vascular dementia occurs when blood vessels that deliver blood to the brain become damaged. Our blood contains oxygen and nutrients that help the brain cells to work properly. When blood vessels are ...

Risk factors are things that change our likelihood of developing a disease. Factors that may increase our risk of developing vascular dementia include age, genetics, lifestyle, and other health ...

Emphasizing the spatial molecular pattern behind blood-brain barrier disruption and loss of the vascular tone in the acute phase following ischemic stroke reperfusion suggests the gene expression ...